parthenolide and Melanoma

parthenolide has been researched along with Melanoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Li, D; Liu, LP; Liu, N; Zhang, HN1
Czyz, ME; Hartman, ML; Koprowska, K; Sztiller-Sikorska, M1
Czyz, M; Hartman, ML; Nejc, D; Szulawska-Mroczek, A; Wozniak, M1
Czyz, M; Hartman, ML; Nejc, D; Sztiller-Sikorska, M; Talar, B1
Czyz, M; Düchler, M; Koprowska, K; Lesiak, K; Nejc, D; Zalesna, I1
Czyz, M; Koprowska, K; Lesiak-Mieczkowska, K; Szulawska-Mroczek, A; Wozniak, M1
Carlisi, D; D'Anneo, A; Di Fiore, R; Emanuele, S; Lauricella, M; Tesoriere, G; Vento, R1
Czyz, M; Koprowska, K; Sztiller-Sikorska, M1

Other Studies

8 other study(ies) available for parthenolide and Melanoma

ArticleYear
Exploring and validating the metastasis mechanism of pathenolide interfering with cutaneous melanoma through ER stress-dependent apoptosis based on the network pharmacology.
    Phytochemical analysis : PCA, 2023, Volume: 34, Issue:7

    Topics: Apoptosis; Atherosclerosis; Drugs, Chinese Herbal; Melanoma; Melanoma, Cutaneous Malignant; Molecular Docking Simulation; Network Pharmacology; Skin Neoplasms

2023
Parthenolide enhances dacarbazine activity against melanoma cells.
    Anti-cancer drugs, 2013, Volume: 24, Issue:8

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interleukin-8; Melanoma; NF-kappa B; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Skin Neoplasms; Vascular Endothelial Growth Factor A

2013
Parthenolide complements the cell death-inducing activity of doxorubicin in melanoma cells.
    Anticancer research, 2013, Volume: 33, Issue:8

    Topics: Cell Death; Cell Line, Tumor; Cell Survival; Doxorubicin; Humans; Melanoma; NF-kappa B; Sesquiterpenes; Tumor Suppressor Protein p53

2013
Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
    Oncotarget, 2016, Feb-23, Volume: 7, Issue:8

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Histone Deacetylase 1; Humans; MAP Kinase Signaling System; Melanoma; Microphthalmia-Associated Transcription Factor; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Sesquiterpenes; Transcription Factor RelA; Tumor Cells, Cultured

2016
Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
    Melanoma research, 2010, Volume: 20, Issue:1

    Topics: Acetylcysteine; Adult; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Drug Interactions; Female; Flow Cytometry; Humans; Male; Melanoma; Membrane Potential, Mitochondrial; Mice; Middle Aged; Reactive Oxygen Species; Sesquiterpenes; Skin Neoplasms; Tanacetum parthenium

2010
Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
    British journal of pharmacology, 2010, Volume: 160, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Proteins; NF-kappa B; Sesquiterpenes

2010
Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells.
    Journal of cellular physiology, 2013, Volume: 228, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis Inducing Factor; Caspase Inhibitors; Caspases; Cell Death; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Melanoma; NADPH Oxidases; NF-kappa B; Osteosarcoma; Reactive Oxygen Species; Sesquiterpenes

2013
Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
    Cancer biology & therapy, 2013, Volume: 14, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Melanoma; Neoplastic Stem Cells; Sesquiterpenes; Spheroids, Cellular; Tumor Cells, Cultured

2013